Scarborough Health Network (SHN) is pleased to be accepting referrals for patients eligible for Evusheld, including transplant patients who live in the Scarborough area who have not already received Evusheld from their transplant centre.
Evusheld is a drug that may prevent you from getting sick from COVID-19. Evusheld is given to people who are currently well and do NOT have COVID-19 but are at higher risk of getting infected. Protection from Evusheld lasts for at least 6 months.
- Evusheld is NOT recommended as a substitute for COVID-19 vaccination in individuals for whom COVID-19 vaccination is recommended. Vaccination provides the best protection against COVID-19, so it is important to get ALL doses of the COVID-19 vaccine that you are eligible for.
- Evusheld is NOT a treatment for COVID-19 or to prevent symptoms if you test positive for COVID-19.
- Evusheld is a combination of two monoclonal antibodies (tixagevimab and cilgavimab) that bind to the COVID-19 virus and prevent it from entering your body to decrease the chance of getting sick from COVID-19.
- Evusheld is given as two shots (one shot into the side of each buttock) by a nurse.
Who is eligible for Evusheld?
Evusheld is given to people may not get enough protection from COVID-19 vaccine alone or at risk of getting very sick from COVID-19. Ontario Health recommends Evusheld for people who:
- Are age 12 and older AND
- Weigh at least 40 kg AND
- Are not currently infected with COVID-19 AND
- Have not had a known recent exposure to an individual infected with COVID-19 (E.g. within 8 days) AND
- Have one of the following: Solid organ transplant (lung, heart, kidney, etc); Stem cell transplant; CAR T-cell therapy; Treatment for blood cancer such as leukemia
What are the side effects of Evusheld?
- Common: may affect up to 13 in 1,000 people
– Pain, redness, itching or swelling where the shot was given
– Itchy red rash or raised bumps
- Less common: may affect less than 1 in 100 people
– Injection related reaction (examples of these include headache, chills
and redness, discomfort or soreness near where the injection was given)
– Cardiac (heart) events have been reported, but were not common. In
people who have experienced serious cardiac events, it was not known
if these events are related to Evusheld or due to the person’s underlying
– Serious allergic reaction such as swelling of the face, tongue, or throat, difficulty breathing or swallowing.
SHN COVID-19 Prophylaxis Clinic
(Located at the same location as the SHN COVID-19 Vaccine Clinic)
1st Floor Margaret Birch Wing
2867 Ellesmere Rd., Scarborough
Phone: 416-284-8131 ext. 7788
Make a Referral
Referral from a physician or a Clinical Assessment Centre required. Please fax the completed referral form to 416-623-1213.
Note: Current patients of SHN’s Oncology and/or Haematology program who have blood cancer will be identified and assessed for Evusheld eligibility and do not require a referral.